Obesity News

People with a higher genetic risk for obesity may need to perform more physical activity to prevent obesity, according to findings published in JAMA Network Open.

Apple cider vinegar might be an effective dietary intervention in the management of obesity, results from a randomized clinical study showed.

Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.

Excess body weight may be a key risk factor for the development of early-onset colorectal cancer, according to research published in International Journal of Cancer.

Medicare Part D plans can begin to cover semaglutide to lower risk for cardiovascular events among adults with overweight or obesity and preexisting CVD, according to new guidance from the Centers of Medicare & Medicaid Services.

Girls with obesity or overweight were more likely to see their general practitioner for a musculoskeletal consultation, according to a study published in Archives of Disease in Childhood.

Children who have two parents with obesity are six times more likely to develop obesity as adults than those who have two parents with normal weight, according to findings that will be presented at the European Congress on Obesity.

Hormone therapy was associated with an improved weight-loss response for postmenopausal women with overweight or obesity treated with semaglutide, according to cohort study results published in Menopause.

An op-ed published in February by Tom Frieden, MD, MPH, former director of the CDC, described hypertension as “the deadliest but most neglected and widespread pandemic of our time” — and he’s right.

Childhood amblyopia, or “lazy eye,” was associated with increased likelihood of cardiometabolic risk factors in adulthood and a potential for increased risk for heart attack and death, researchers reported.